Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Gibbs

Showing results (271-280 of 427) with videos related to

Pageof 43
Sort By:
European Journal of Cancer (Oxford, England : 1990)|August 21, 2022
Impact of first-line FOLFIRINOX versus Gemcitabine/Nab-Paclitaxel chemotherapy on survival in advanced pancreatic cancer: Evidence from the prospective international multicentre PURPLE pancreatic cancer registryJordan Santucci, Mark Tacey, Benjamin Thomson, et al.
Acta Oncologica (Stockholm, Sweden)|June 29, 2021
Stage dependent recurrence patterns and post-recurrence outcomes in non-metastatic colon cancerLucy Gately, Azim Jalali, Christine Semira, et al.
BMC Cancer|June 2, 2022
Beyond standard data collection - the promise and potential of BRAIN (Brain tumour Registry Australia INnovation and translation registry)Lucy Gately, Katharine Drummond, Mark Rosenthal, et al.
Cancer Biomarkers : Section a of Disease Markers|July 11, 2013
Performance of serum lipocalin 2 as a diagnostic marker for colorectal cancerKim Y C Fung, Ilka Priebe, Leanne Purins, et al.
Cancers|October 26, 2024
Evolving Practice and Outcomes in Grade 2 Glioma: Real-World Data from a Multi-Institutional RegistryLucy Gately, Katharine Drummond, Anthony Dowling, et al.
Nanoscale|August 21, 2015
Chelator free gallium-68 radiolabelling of silica coated iron oxide nanorods via surface interactionsBenjamin P Burke, Neazar Baghdadi, Alicja E Kownacka, et al.
Contemporary Clinical Trials|August 3, 2020
Cancer history and risk factors in healthy older people enrolling in the ASPREE clinical trialSuzanne G Orchard, Jessica E Lockery, Peter Gibbs, et al.
Clinical Colorectal Cancer|May 24, 2025
Exploring Real-World Outcomes of First Line EGFR Inhibitor Use, Cetuximab Versus Panitumumab, in Patients with Left-Sided, RAS Wild-Type, Metastatic Colorectal CancerJane McKenzie, Vanessa Wong, Shehara Mendis, et al.
The Medical Journal of Australia|July 22, 2008
Feasibility of conducting a primary prevention trial of low-dose aspirin for major adverse cardiovascular events in older people in Australia: results from the ASPirin in Reducing Events in the Elderly (ASPREE) pilot studyMark R Nelson, Christopher M Reid, David A Ames, et al.
JCO Clinical Cancer Informatics|June 26, 2024
Improving Clinical Registry Data Quality via Linkage With Survival Data From State-Based Population RegistriesSamuel Smith, Kate Drummond, Anthony Dowling, et al.
Pageof 43

Showing results (271-280 of 427) with videos related to

Sort By:
Pageof 43
European Journal of Cancer (Oxford, England : 1990)|August 21, 2022
Impact of first-line FOLFIRINOX versus Gemcitabine/Nab-Paclitaxel chemotherapy on survival in advanced pancreatic cancer: Evidence from the prospective international multicentre PURPLE pancreatic cancer registryJordan Santucci, Mark Tacey, Benjamin Thomson, et al.
Acta Oncologica (Stockholm, Sweden)|June 29, 2021
Stage dependent recurrence patterns and post-recurrence outcomes in non-metastatic colon cancerLucy Gately, Azim Jalali, Christine Semira, et al.
BMC Cancer|June 2, 2022
Beyond standard data collection - the promise and potential of BRAIN (Brain tumour Registry Australia INnovation and translation registry)Lucy Gately, Katharine Drummond, Mark Rosenthal, et al.
Cancer Biomarkers : Section a of Disease Markers|July 11, 2013
Performance of serum lipocalin 2 as a diagnostic marker for colorectal cancerKim Y C Fung, Ilka Priebe, Leanne Purins, et al.
Cancers|October 26, 2024
Evolving Practice and Outcomes in Grade 2 Glioma: Real-World Data from a Multi-Institutional RegistryLucy Gately, Katharine Drummond, Anthony Dowling, et al.
Nanoscale|August 21, 2015
Chelator free gallium-68 radiolabelling of silica coated iron oxide nanorods via surface interactionsBenjamin P Burke, Neazar Baghdadi, Alicja E Kownacka, et al.
Contemporary Clinical Trials|August 3, 2020
Cancer history and risk factors in healthy older people enrolling in the ASPREE clinical trialSuzanne G Orchard, Jessica E Lockery, Peter Gibbs, et al.
Clinical Colorectal Cancer|May 24, 2025
Exploring Real-World Outcomes of First Line EGFR Inhibitor Use, Cetuximab Versus Panitumumab, in Patients with Left-Sided, RAS Wild-Type, Metastatic Colorectal CancerJane McKenzie, Vanessa Wong, Shehara Mendis, et al.
The Medical Journal of Australia|July 22, 2008
Feasibility of conducting a primary prevention trial of low-dose aspirin for major adverse cardiovascular events in older people in Australia: results from the ASPirin in Reducing Events in the Elderly (ASPREE) pilot studyMark R Nelson, Christopher M Reid, David A Ames, et al.
JCO Clinical Cancer Informatics|June 26, 2024
Improving Clinical Registry Data Quality via Linkage With Survival Data From State-Based Population RegistriesSamuel Smith, Kate Drummond, Anthony Dowling, et al.
Pageof 43